152 related articles for article (PubMed ID: 20183863)
1. Effect of deviation from the mid-sagittal plane on the measurement of fetal nuchal translucency.
Abele H; Wagner N; Hoopmann M; Grischke EM; Wallwiener D; Kagan KO
Ultrasound Obstet Gynecol; 2010 May; 35(5):525-9. PubMed ID: 20183863
[TBL] [Abstract][Full Text] [Related]
2. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
[TBL] [Abstract][Full Text] [Related]
3. Image Settings Affecting Nuchal Translucency Measurement Using Volume NT Software.
Cho HY; Kim YH; Park YW; Kim SY; Lee KH; Yoo JS; Kwon JY
Yonsei Med J; 2015 Sep; 56(5):1345-51. PubMed ID: 26256978
[TBL] [Abstract][Full Text] [Related]
4. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
6. How true is a 'true' midsagittal section?
Wah YM; Chan LW; Leung TY; Fung TY; Lau TK
Ultrasound Obstet Gynecol; 2008 Dec; 32(7):855-9. PubMed ID: 18973236
[TBL] [Abstract][Full Text] [Related]
7. Impact of tissue harmonic imaging on measurement of nuchal translucency thickness.
Pasquini L; Tondi F; Rizzello F; Pontello V; Paoletti E; Fontanarosa M
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):423-6. PubMed ID: 20205154
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
9. Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience.
Abele H; Hoopmann M; Wright D; Hoffmann-Poell B; Huettelmaier M; Pintoffl K; Wallwiener D; Kagan KO
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):417-22. PubMed ID: 20734371
[TBL] [Abstract][Full Text] [Related]
10. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21.
Kagan KO; Wright D; Etchegaray A; Zhou Y; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):657-64. PubMed ID: 19408250
[TBL] [Abstract][Full Text] [Related]
11. Nuchal translucency measurement in first trimester Down syndrome screening.
Scott A
Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
[TBL] [Abstract][Full Text] [Related]
12. Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
Paul C; Krampl E; Skentou C; Jurkovic D; Nicolaides KH
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):481-4. PubMed ID: 11844168
[TBL] [Abstract][Full Text] [Related]
13. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
14. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
15. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
17. Likelihood ratio-based quality control for nuchal translucency measurements at 11-14 weeks of gestation.
Salomon LJ; Porcher R; Stirnemann JJ; Bernard JP; Ville Y
Ultrasound Obstet Gynecol; 2011 May; 37(5):576-81. PubMed ID: 20814879
[TBL] [Abstract][Full Text] [Related]
18. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
20. Semi-automated system for measurement of nuchal translucency thickness.
Moratalla J; Pintoffl K; Minekawa R; Lachmann R; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):412-6. PubMed ID: 20617517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
